Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000895345-25-000001·BCTG Holdings, LLC
Schedule 13D ownership disclosure
Tango Therapeutics Inc
Common Stock, $0.001 par value per share · CUSIP: 87583X109
Event date: 2024-12-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BCTG Holdings, LLCReported CIK 0001823427
Shares: 0 · Class: 0%
- MVA Investors, LLCReported CIK 0001468223
Shares: 326,886 · Class: 0.3%
- Davis Aaron I.Reported CIK 0001465914
Shares: 10,740,385 · Class: 10%
- Boxer Capital Management, LLCReported CIK 0002018299
Shares: 10,380,999 · Class: 9.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895345-25-000001
- Form type
- SCHEDULE 13D/A
- Filer
- BCTG Holdings, LLC
- CIK
- CIK 1823427
- Filed
- Jan 02, 2025
- Reporting period
- Dec 30, 2024
- Description
- Schedule 13D beneficial ownership